NCT03748212

Clinical Trial to Evaluate Pharmacokinetic Profiles and Safety Between CKD-385 and D935 in Healthy Volunteers

A Randomized, Open-label, Fed, Single Dose, Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 52 (estimated)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

A randomized, open-label, fed, single dose, crossover study to evaluate the pharmacokinetic profiles and safety of CKD-385 in healthy volunteers

Detailed description

To healthy subjects of 52, following treatments are administered dosing in each period and wash-out period is a minimum of 7 days.

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	D935 Cap. 1T	single oral administration under fed condition
DRUG	CKD-385 Tab. 1T	single oral administration under fed condition

Timeline

• Start date: 2018-10-24
• Primary completion: 2018-12-01
• Completion: 2018-12-01
• First posted: 2018-11-20
• Last updated: 2018-12-31

Locations

1 site across 1 country: South Korea